Introducing Endpoints Studio, a new way to advertise with Endpoints-crafted branding campaigns
Since our start in 2016, Endpoints News has grown fast while executing our mission to cover biopharma’s most critical developments for industry pros worldwide. As readership has grown, our advertising business has too. Endpoints advertising partners support the mission and engage their desired audiences through announcements on our email and web platforms, brand recognition in our event coverage and sponsorships of Endpoints daily and weekly reports.
And today, we’re launching our newest evolution of the business: Endpoints Studio.
Now, life sciences marketers can produce branded content in the caliber readers expect from Endpoints. Led by Kari Abitbol, our new head of advertising and marketing programs, the Endpoints Studio team develops measurable campaigns informed with our first-party data.
Our lineup features the Studio FSP and Studio FSP+, an enhancement of our long-established sponsored posts with articles authored by our Studio team — with an opportunity to do lead-capture. Studio FSP and FSP+ benefit from the same, exclusive promotion across our email reports, homepage and news streams. We’re also introducing Studio webinars, which run like custom and editorial webinars but are programmed exclusively by our Studio team, and E-blast+, which includes an Endpoints-created and hosted landing page designed for high conversion.
So what makes Endpoints Studio different, exactly? Check out the new studio website to learn more about our products, topics (which span cell and gene therapy to pharma marketing) and how we use our own data to deliver better content for our readers and stronger results for our advertisers. And soon, you’ll see case studies about how we’re learning from our own Studio programs to generate even greater impact.
In 2021, our commitment was to go broader and deeper. We launched four weekly reports — Endpoints Manufacturing, Endpoints Weekly, Endpoints FDA+ and the newly released Endpoints MarketingRx — and delivered breaking news that fueled a wave of new subscribers. Our active email daily readership is nearing 125,000 subscribers as we close out the year. We’ve grown our team from 22 full-time staff in January to 35 full-time employees (and counting) to mature and support these initiatives at scale.
As we look to the year ahead, we’re greatly thankful for the continued support from readers, subscribers and sponsors that has catapulted us from a small media company into a thriving force whose work is seen daily by leadership at the top 25 pharma companies and thousands of biotech startups across the globe. And we’re just getting started.
Stay tuned for more Endpoints Studio updates from Kari next year. For Studio scheduling and pricing requests, contact our Studio sales team here.